COM:CANDELTX
Candel Therapeutics
- Stock
Last Close
4.13
22/11 21:00
Market Cap
178.24M
Beta: -
Volume Today
2.30M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | ||||||
average payables | 569.50K - | 1.26M 120.46% | 985K 21.55% | 401K 59.29% | ||
average receivables | ||||||
book value per share | -0.43 - | -1.26 192.62% | 3.40 369.92% | -3.44 201.16% | 0.44 112.81% | |
capex per share | -0.01 - | -0.08 826.69% | -0.10 23.28% | -0.04 53.72% | -0.02 64.90% | |
capex to depreciation | -3.70 - | -16.22 338.65% | -7.91 51.24% | -1.67 78.92% | -0.38 77.16% | |
capex to operating cash flow | 0.03 - | 0.16 429.80% | 0.08 49.24% | 0.04 50.02% | 0.01 67.67% | |
capex to revenue | -1.27 - | -11.81 828.30% | -14.68 24.32% | -10.38 29.32% | ||
cash per share | 2.41 - | 1.87 22.34% | 4.38 133.78% | 2.43 44.49% | 1.22 49.65% | |
days of inventory on hand | ||||||
days payables outstanding | 128.36 - | |||||
days sales outstanding | ||||||
debt to assets | 0.01 - | 0.02 170.07% | 0.01 74.60% | 0.29 4,574.82% | 0.52 78.04% | |
debt to equity | -0.05 - | -0.04 23.16% | 0.01 121.75% | -0.23 2,735.30% | 1.71 843.00% | |
dividend yield | ||||||
earnings yield | -0.06 - | -0.17 176.21% | -0.25 44.81% | -0.06 77.34% | -0.89 1,505.70% | |
enterprise value | 126.01M - | 96.89M 23.11% | 65.51M 32.39% | 4.34M 93.38% | 29.88M 589.20% | |
enterprise value over ebitda | -16.63 - | -11.41 31.36% | -2.68 76.49% | -0.08 96.83% | -0.80 845.91% | |
ev to operating cash flow | -24.34 - | -10.68 56.12% | -2.95 72.40% | -0.14 95.32% | -0.87 532.34% | |
ev to sales | 1.01K - | 775.15 23.11% | 524.04 32.39% | 34.69 93.38% | ||
free cash flow per share | -0.29 - | -0.56 97.31% | -1.27 126.14% | -1.14 10.94% | -1.20 5.66% | |
free cash flow yield | -0.04 - | -0.08 97.31% | -0.16 102.43% | -0.63 289.08% | -0.82 28.66% | |
graham net net | -0.48 - | -1.43 201.11% | 3.05 313.09% | 1.39 54.42% | 0.22 83.95% | |
graham number | 2.04 - | 5.79 184.30% | 12.11 108.97% | 2.77 77.09% | 3.60 29.98% | |
income quality | 0.63 - | 0.51 18.34% | 0.62 19.88% | 1.67 171.81% | 0.90 46.01% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | |
interest coverage | -485.40 - | -70.86 85.40% | 14.79 120.88% | |||
interest debt per share | 0.02 - | 0.05 124.85% | 0.03 35.75% | 0.81 2,387.74% | 0.66 17.91% | |
inventory turnover | ||||||
invested capital | -0.05 - | -0.04 23.16% | 0.01 121.75% | -0.23 2,735.30% | 1.71 843.00% | |
market cap | 130.77M - | 131.00M 0.17% | 147.59M 12.66% | 51.59M 65.04% | 42.53M 17.56% | |
net current asset value | -8.73M - | -26.70M 205.85% | 59.88M 324.28% | 41.97M 29.91% | 7.84M 81.32% | |
net debt to ebitda | 0.63 - | 4.02 539.78% | 3.36 16.32% | 0.93 72.46% | 0.34 63.26% | |
net income per share | -0.43 - | -1.18 176.21% | -1.92 61.78% | -0.10 94.81% | -1.31 1,218.65% | |
operating cash flow per share | -0.28 - | -0.48 74.91% | -1.18 142.87% | -1.09 7.41% | -1.18 8.57% | |
payables turnover | 2.84 - | |||||
receivables turnover | ||||||
research and ddevelopement to revenue | 52.86 - | 70.03 32.50% | 121.42 73.38% | 166.30 36.95% | ||
return on tangible assets | -0.17 - | -0.58 231.76% | -0.41 29.98% | -0.04 90.90% | -0.91 2,366.17% | |
revenue per share | 0.01 - | 0.01 0.17% | 0.01 0.84% | 0.00 34.52% | ||
roe | 1.00 - | 0.94 5.61% | -0.56 159.94% | 0.03 105.13% | -2.98 10,391.89% | |
roic | 1.15 - | 0.77 33.62% | -0.40 152.00% | 0.07 117.89% | -1.08 1,618.00% | |
sales general and administrative to revenue | 20.44 - | 41.45 102.78% | 85.38 106.00% | 112.48 31.73% | ||
shareholders equity per share | -0.43 - | -1.26 192.62% | 3.40 369.92% | -3.44 201.16% | 0.44 112.81% | |
stock based compensation to revenue | 3.20 - | 16.86 426.75% | 23.70 40.63% | 18.46 22.14% | ||
tangible asset value | -8.04M - | -23.56M 193.13% | 64.14M 372.21% | 47.71M 25.61% | 12.74M 73.29% | |
tangible book value per share | -0.43 - | -1.26 192.62% | 3.40 369.92% | 1.66 51.29% | 0.44 73.39% | |
working capital | 43.80M - | 30.43M 30.52% | 79.58M 161.50% | 66.33M 16.65% | 22.61M 65.91% |
All numbers in USD (except ratios and percentages)